Roni Caryn Rabin / nytimes - The benefits of hormone replacement have been underappreciated, Dr. Marty Makary, the agency’s commissioner, said on Monday. Critics described evidence for the change as insufficient.
#healthcare #pharmaceuticals #publichealth #governmentpolicy #fda
Saturday, November 15, 2025, 10:21 am / permalink 15996 / 3 stories in 4 months
EPA proposes rollback on ethylene oxide sterilizer emissions (28 min)
Two deaths prompt probe of paid plasma donation clinics in Winnipeg (1 hr)
HIMSS 2026 pushes real‑time data, cloud and interoperability playbook (18 hrs)
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.